| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |